Skip to content

Clinical trials

Frailty trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Frailty Country / region: China Clear all

60 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20141
20151
20182
20193
20207
202112
20221
20239
20249
20259
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Unknown status15
Recruiting11
Not yet recruiting4
Enrolling by invitation3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Nanjing Medical University5
Chinese PLA General Hospital3
Chinese University of Hong Kong2
Huashan Hospital2
Peking Union Medical College Hospital2
The University of Hong Kong2
Xuanwu Hospital, Beijing2
Affiliated Hospital of Nantong University1
Ailin Luo1
Beijing Anzhen Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Frailty60
Sarcopenia7
Emergence Delirium4
Cognitive Dysfunction3
Diabetes Mellitus3
Malnutrition3
Stomach Neoplasms3
Atrial Fibrillation2
Cardiovascular Diseases2
Cognition Disorders2

Trials

Showing 1 to 25 of 60. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.